abstract |
The present invention relates to medicaments of formula (I) useful for the treatment and/or prophylaxis of mammals, in particular to NF-κB-inducible kinases (NIK- - Also known as an inhibitor of MAP3K14). The present invention also relates to pharmaceutical compositions comprising such compounds, and the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders . |